ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture,...
ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture,...
ABVC Biopharma與Oncox Biopharma之間的合作，ABVC預計總收入爲1375萬美元，特許權使用費高達1,250萬美元；授予Oncox在其腫瘤學產品線中的四種產品之一的獨家權利，用於開發、製造...
ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture, Commercialize Blex 404
ABVC Biopharma與Oncox Biopharma之間的合作，ABVC預計總收入爲1375萬美元，特許權使用費高達1,250萬美元；授予Oncox對Abvc在其腫瘤學產品線中的四種產品之一的獨家權利，用於開發、製造和商業化Blex 404
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。